Lermed Revenue

Biotechnology Research • Lausanne, Vaud, Switzerland • 1-10 Employees

Lermed revenue & valuation

Annual revenue	$256,665
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$821,328
Total funding	No funding

Key Contact at Lermed

Sylvain Perriot

Co-Founder

Company overview

Headquarters	Lausanne, Vaud, Switzerland
Website	lermed.ch
NAICS	541714
Keywords	Biotechnology, Biomarkers, Stem Cells, Neurodegeneration, Liquid Biopsy, Clinical-Trials-In-A-Dish
Employees	1-10

About Lermed

Lermed is developing several approaches to improve diagnosis, prognosis and overall care for patients with neurodegenerative diseases. It leverages two proprietary platforms to generate in-vitro avatars of patients, thus reproducing disease states to conduct clinical trials in a dish, identify responders and devise companion tests for drug development. This groundbreaking approach has the potential to unlock personalised medicine in the field of neurodegeneration and dementia.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Founder/Owner

Employees by Department

Lermed has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Lermed has never raised funding before.

Frequently asked questions

Lermed is located in Lausanne, Vaud, CH.

Lermed generates an estimated annual revenue of $256,665. This revenue figure reflects the company's market position and business performance in its industry.

Lermed has an estimated valuation of $821,328. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Lermed has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Lermed

Sylvain Perriot

Co-Founder

4.8

40,000 users